Neurocrine Biosciences Inc (NASDAQ:NBIX)

39.05
Delayed Data
As of Feb 27
 -1.00 / -2.50%
Today’s Change
12.17
Today|||52-Week Range
40.75
+74.80%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close40.05
Today’s open40.00
Day’s range38.65 - 40.50
Volume1,825,819
Average volume (3 months)1,240,974
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-23.40%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book14.31

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.41-1.01%
WXWuxi Pharmatech Caym...-0.59-1.46%
ACADACADIA Pharmaceutica...+0.19+0.50%
MNKDMannkind Corp-0.30-4.40%
Data as of 4:04pm ET, 02/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account